Envestnet Portfolio Solutions
IBB icon

Envestnet Portfolio Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Envestnet Portfolio Solutions’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,947
Closed -$4.21M – 1409
2026
Q1 		$4.21M Buy
24,947
+1,384
+6% +$237K 0.02% 315
2025
Q4 		$3.98M Buy
+23,563
New +$3.83M 0.01% 406

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Envestnet Portfolio Solutions's IBB Position: Q2 2026 in Review

Envestnet Portfolio Solutions sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 24,947 shares — an estimated $4.21M sold.

Envestnet Portfolio Solutions first reported a position in IBB in Q4 2025 and held it in 2 quarters. The position peaked at $4.21M in Q1 2026. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Envestnet Portfolio Solutions reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 24,947 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.21M.
  • Envestnet Portfolio Solutions first reported a position in iShares Biotechnology ETF in Q4 2025 and held it in 2 quarters.
  • Envestnet Portfolio Solutions's iShares Biotechnology ETF position peaked at $4.21M in Q1 2026.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.